Updates in the management of polycythemia vera and essential thrombocythemia

Por Prithviraj Bose, Srdan Verstovsek
Publicado em 2019-08-01

GLI1 activates pro-fibrotic pathways in myelofibrosis fibrocytes

Por Taghi Manshouri, Ivo Veletic, Ping Li, C. Cameron Yin, Sean M. Post, Srdan Verstovsek, Zeev Estrov
Publicado em 2022-05-01

A phase Ib study to assess the efficacy and safety of vismodegib in combination with ruxolitinib in patients with intermediate- or high-risk myelofibrosis

Por Stephen Couban, Giulia Benevolo, William Donnellan, Jennifer Cultrera, Steffen Koschmieder, Srdan Verstovsek, Gregory Hooper, Christian Hertig, Maneesh Tandon, Natalie Dimier, Vikram Malhi, Francesco Passamonti
Publicado em 2018-09-01